NASDAQ:NRSN

NeuroSense Therapeutics Ltd.

Stock

USD

Last Close

0.76

30/08 20:00

Market Cap

17.50M

Beta: -

Volume Today

1.35M

Avg: 65.36K

PE Ratio

−1.38

PFCF: -

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-1.22M -	-2.83M 131.42%	-4.04M 42.89%	-12.34M 205.37%	-11.28M 8.59%
depreciation and amortization		3K -	3K 0%	89K 2,866.67%	97K 8.99%
deferred income tax		2K -	-2.72M 136,300%		-2.01M -
stock based compensation	611K -	2.06M 237.32%	4.16M 101.80%	5.11M 22.75%	2.80M 45.19%
change in working capital	29K -	69K 137.93%	273K 295.65%	750K 174.73%	1.91M 154.40%
accounts receivables	-3.00K -	-12K 300.00%	-204K 1,600%	55K 126.96%	19K 65.45%
inventory	3.00K -	12K 300.00%	204K 1,600%	-55K 126.96%
accounts payables	23K -	32K 39.13%	-16K 150%	459K 2,968.75%	961K 109.37%
other working capital	6K -	37K 516.67%	289K 681.08%	291K 0.69%	928K 218.90%
other non cash items		-2K -	791K 39,650%	-1.19M 250.44%	-1.80M 51.01%
net cash provided by operating activities	-582K -	-695K 19.42%	-1.54M 121.44%	-7.59M 392.92%	-8.27M 9.07%
investments in property plant and equipment	-7K -	-9K 28.57%	-17K 88.89%	-70K 311.76%	-29K 58.57%
acquisitions net					3.00K -
purchases of investments	-19K -			-3.50M -	-3.00K 99.91%
sales maturities of investments					3.50M -
other investing activites				29K -	0.00 100.00%
net cash used for investing activites	-26K -	-9K 65.38%	-17K 88.89%	-3.54M 20,729.41%	3.47M 197.94%
debt repayment	-3K -		-1.24M -	-79K 93.62%	-80K 1.27%
common stock issued	1.42M -	508K 64.23%	9.86M 1,841.73%	3.87M 60.77%	3.98M 2.71%
common stock repurchased
dividends paid
other financing activites	-3.00K -	508 116.93%	3.28M 644,781.89%	-96K 102.93%
net cash used provided by financing activities	1.42M -	508K 64.15%	11.90M 2,242.91%	3.69M 68.95%	3.90M 5.41%
effect of forex changes on cash			18K -	-88K 588.89%	8K 109.09%
net change in cash	809K -	-196K 124.23%	10.36M 5,387.76%	-7.52M 172.56%	-899K 88.05%
cash at beginning of period	86K -	895K 940.70%	699K 21.90%	11.06M 1,482.69%	3.58M 67.65%
cash at end of period	895K -	699K 21.90%	11.06M 1,482.69%	3.54M 67.97%	2.68M 24.36%
operating cash flow	-582K -	-695K 19.42%	-1.54M 121.44%	-7.59M 392.92%	-8.27M 9.07%
capital expenditure	-7K -	-9K 28.57%	-17K 88.89%	-70K 311.76%	-29K 58.57%
free cash flow	-589K -	-704K 19.52%	-1.56M 121.02%	-7.66M 392.03%	-8.30M 8.45%

All numbers in USD (except ratios and percentages)